Diabetes new treatment 2018

Here are some new diabetes treatments that were approved or made significant progress in 2018:

  1. Ozempic (semaglutide): Approved in June 2018, Ozempic is a once-weekly injectable medication that combines glucagon-like peptide-1 (GLP-1) receptor agonism with insulin secretion. It is used to treat type 2 diabetes and has been shown to reduce the risk of cardiovascular events.
  2. Invokana (canagliflozin): In August 2018, the FDA approved a new indication for Invokana, which is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. The medication is now approved to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease.
  3. Jardiance (empagliflozin): In June 2018, the FDA approved a new indication for Jardiance, which is also an SGLT2 inhibitor. The medication is now approved to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
  4. Farxiga (dapagliflozin): In August 2018, the FDA approved a new indication for Farxiga, which is also an SGLT2 inhibitor. The medication is now approved to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
  5. Tresiba (insulin degludec): In June 2018, the FDA approved a new indication for Tresiba, which is a long-acting insulin analog. The medication is now approved to be used in combination with other diabetes medications to improve glycemic control in adults with type 2 diabetes.
  6. Xultophy (insulin 70/30): In June 2018, the FDA approved a new indication for Xultophy, which is a combination of insulin glargine and lixisenatide. The medication is now approved to improve glycemic control in adults with type 2 diabetes.
  7. Oral semaglutide: In June 2018, the FDA approved oral semaglutide, a once-daily tablet that combines GLP-1 receptor agonism with insulin secretion. It is used to treat type 2 diabetes and has been shown to reduce the risk of cardiovascular events.

These are just a few examples of the new diabetes treatments that were approved or made significant progress in 2018. There are many more treatments in development, and researchers continue to explore new ways to manage and treat diabetes.